NASDAQ:DOCS Doximity (DOCS) Stock Price, News & Analysis $57.96 +1.24 (+2.19%) Closing price 04/2/2025 03:52 PM EasternExtended Trading$57.19 -0.77 (-1.33%) As of 04:30 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About Doximity Stock (NASDAQ:DOCS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Doximity alerts:Sign Up Key Stats Today's Range$55.13▼$58.8850-Day Range$55.38▼$83.1152-Week Range$22.96▼$85.21Volume1.82 million shsAverage Volume1.93 million shsMarket Capitalization$10.82 billionP/E Ratio57.96Dividend YieldN/APrice Target$64.22Consensus RatingModerate Buy Company OverviewDoximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.Read More… Remove Ads Doximity Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks66th Percentile Overall ScoreDOCS MarketRank™: Doximity scored higher than 66% of companies evaluated by MarketBeat, and ranked 340th out of 927 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingDoximity has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on 8 buy ratings, 11 hold ratings, and no sell ratings.Amount of Analyst CoverageDoximity has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Doximity's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth8.08% Earnings GrowthEarnings for Doximity are expected to grow by 8.08% in the coming year, from $0.99 to $1.07 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Doximity is 57.96, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.55.Price to Earnings Ratio vs. SectorThe P/E ratio of Doximity is 57.96, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.12.Price to Earnings Growth RatioDoximity has a PEG Ratio of 4.10. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDoximity has a P/B Ratio of 10.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for DOCS. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDoximity does not currently pay a dividend.Dividend GrowthDoximity does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for DOCS. News and Social Media2.9 / 5News Sentiment1.22 News SentimentDoximity has a news sentiment score of 1.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Doximity this week, compared to 10 articles on an average week.Search InterestOnly 23 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -28% compared to the previous 30 days.MarketBeat Follows17 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is an increase of 13% compared to the previous 30 days. Company Ownership4.2 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,152,400.00 in company stock.Percentage Held by Insiders37.40% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Doximity's insider trading history. Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter. Email Address DOCS Stock News HeadlinesAnalysts Have Conflicting Sentiments on These Healthcare Companies: Doximity (DOCS) and Diaceutics (OtherDIUXF)March 26, 2025 | theglobeandmail.comLauren Balik short Doxomity, calls company ‘a predatory business’March 26, 2025 | markets.businessinsider.comTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed.April 3, 2025 | Porter & Company (Ad)Here’s How Doximity (DOCS) Regained Investors’ TrustMarch 21, 2025 | msn.com2 Software Stocks on Our Watchlist and 1 to IgnoreMarch 17, 2025 | finance.yahoo.comDOXIMITY SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Doximity, Inc. (DOCS) and Encourages Long-Term Investors to Contact the FirmMarch 17, 2025 | markets.businessinsider.comSpotify, Rubrik Lead Five Growth Stocks Regaining This Key LevelMarch 17, 2025 | investors.comDoximity, Inc. (DOCS): Among The Stocks With At Least $10 Million In Insider Sales RecentlyMarch 7, 2025 | insidermonkey.comSee More Headlines DOCS Stock Analysis - Frequently Asked Questions How have DOCS shares performed this year? Doximity's stock was trading at $53.39 at the beginning of the year. Since then, DOCS shares have increased by 8.6% and is now trading at $57.96. View the best growth stocks for 2025 here. How were Doximity's earnings last quarter? Doximity, Inc. (NASDAQ:DOCS) released its quarterly earnings results on Thursday, November, 7th. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.26 by $0.02. The firm earned $136.83 million during the quarter, compared to the consensus estimate of $127.05 million. Doximity had a trailing twelve-month return on equity of 21.75% and a net margin of 36.60%. When did Doximity IPO? Doximity (DOCS) raised $501 million in an initial public offering (IPO) on Thursday, June 24th 2021. The company issued 23,300,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities acted as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers. How do I buy shares of Doximity? Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Doximity own? Based on aggregate information from My MarketBeat watchlists, some other companies that Doximity investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), CrowdStrike (CRWD), PayPal (PYPL) and Invesco QQQ (QQQ). Company Calendar Last Earnings11/07/2024Today4/02/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Custom computer programming services Sub-IndustryComputer Software Current SymbolNASDAQ:DOCS CIK1516513 Webwww.doximity.com Phone650-549-4330FaxN/AEmployees890Year FoundedN/APrice Target and Rating Average Stock Price Target$64.22 High Stock Price Target$90.00 Low Stock Price Target$45.00 Potential Upside/Downside+10.8%Consensus RatingModerate Buy Rating Score (0-4)2.57 Research Coverage21 Analysts Profitability EPS (Most Recent Fiscal Year)$1.00 Trailing P/E Ratio57.96 Forward P/E Ratio58.55 P/E Growth4.1Net Income$147.58 million Net Margins36.60% Pretax Margin46.01% Return on Equity21.75% Return on Assets18.64% Debt Debt-to-Equity RatioN/A Current Ratio8.74 Quick Ratio8.74 Sales & Book Value Annual Sales$550.17 million Price / Sales19.67 Cash Flow$0.71 per share Price / Cash Flow81.32 Book Value$5.52 per share Price / Book10.50Miscellaneous Outstanding Shares186,692,000Free Float116,869,000Market Cap$10.82 billion OptionableNot Optionable Beta1.34 10 Stocks Set to Soar in Spring 2025Market volatility creates opportunity. Our analysts have pinpointed 10 stocks perfectly positioned for exceptional growth this spring, even amid economic uncertainty. Don't miss your chance to access this timely research and invest with confidence.Get This Free Report This page (NASDAQ:DOCS) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Doximity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Doximity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.